Patent details

Basic Information

Publication number:

EP2646052

PCT Application Number:

US2011063037

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118450535

PCT Publication Number:

WO2012075376

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

LYOPHILIZED VIRAL FORMULATIONS

French Title of Invention:

FORMULATIONS DE VIRUS LYOPHILISÉES

German Title of Invention:

LYOPHILISIERTE VIRALE FORMULIERUNGEN

SPC Number:

Dates

Filing date:

02/12/2011

Grant date:

29/03/2017

EP Publication Date:

09/10/2013

PCT Publication Date:

07/06/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/03/2017

EP B1 Publication Date:

29/03/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/12/2017

Expiration date:

02/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/03/2017

 

 

Name:

Oncolytics Biotech Inc.

Address:

Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:

PAVLIV, Leo

Address:

United States (US)

2

Name:

COFFEY, Matthew C.

Address:

Canada (CA)

3

Name:

SERL, Sarah

Address:

Canada (CA)

Priority

Priority Number:

419020 P

Priority Date:

02/12/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61K 31/70; A61K 39/15; A61K 48/00; A61P 31/00; A61P 31/12;

Publication

European Patent Bulletin

Issue number:

201713

Publication date:

29/03/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2018	Outgoing Correspondence	1